Flumazenil rapidly antagonizes benzodiazepines (BZDs); it may induce agitation, seizure, or
delirium, especially when applied to patients who have taken BZDs for a long time. On the
contrary, it may help patients regain consciousness in a stable and calm state by
appropriately reversing the central nervous system depressant effects of BZDs. In this study,
we aim to investigate the impact of flumazenil on the emergence delirium in patients
anesthetized with remimazolam, the short-acting BZD drug.